skip to content

Other

Genus updates on US litigation

15 August 2016 07:35

Genus, a global pioneer in animal genetics, has reported the final jury verdicts in its litigation against Inguran LLC, operating as Sexing Technologies, relating to ABS's Genus Sexed Semen processing technology.

At the trial, in the US District Court for the Western District of Wisconsin where the jury damages verdict was announced late on Friday, the jury found that Genus should pay ST an upfront payment of $750,000 and an ongoing royalty of $1.25 per straw on commercialisation of the GSS technology for the use of ST's US patent numbers 8,206,987, and $500,000 upfront and $0.50 per straw royalty for the 8,198,092 patent, both of which had been determined by the jury to be valid and infringed.

In respect of ABS's breach of the confidentiality obligations under the 2012 semen sorting agreement between the parties, damages were determined by the jury to be $750,000.

In a verdict delivered on 10 August, the jury determined that ABS and Genus had proved that ST had wilfully maintained monopoly power in the market for sexed bovine semen processing in the US since July 2012. The jury also found that Genus had not proved that it had suffered injury to date as a result of ST's wilful maintenance of monopoly power.

Following the verdict on wilful maintenance of monopoly power by ST, Genus has now sought an injunction from the court to allow, among other things, ABS to terminate the 2012 semen sorting agreement on ninety days notice and to provide relief from the restrictive provisions under that agreement. Genus plans to commercialise its GSS technology in the US and globally and introduce competition into the market.

GSS is a novel technology for sexing bovine semen that does not subject the sperm cells to high pressures and forces. Dairy farmers have a preference for female calves, and the use of gender skewed sexed semen in artificial insemination provides customers with female calves from ABS's elite genetic lines. The commercial launch of GSS product would provide ABS customers and third party bull studs with an alternative service provider and increased competition in the market for the processing of sexed bovine semen.

Genus is now awaiting the court's decision on its request for an injunction and is considering other post verdict motions.

Story provided by StockMarketWire.com

Related Company: GNS

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.